A digital health care platform focused on in vitro fertilization and fertility has raised nearly $15 million in a new round of funding.
TriBeCa-based Progyny, which also offers an embryo-viability-testing system called Eeva, will invest the additional cash in its new app for patients, the company said Wednesday.
The mission of Progyny, which began as an IVF information platform, is making a costly and uncertain procedure more transparent for patients, founder and CEO Gina Bartasi told Crain's.
“What struck me was how opaque the industry was,” said Bartasi, who conceived twins of her own through IVF. “What Progyny is trying to do as a company is take care of the patients in terms of success rates, time of treatment and costs.”
Read Complete Article